LifeMine Therapeutics
- Health & Biotech
- Watertown, MA, US
- Founded 2017
- Private
- lifeminetx.com
Biotech discovering drugs from fungal-derived natural products, with lead candidate LIFE-001 for preventing organ transplant rejection.
$263MEquity raised in 2025–20262025 — · 2026 $263M · 2 equity rounds
$263MEquity raised, all time2 equity rounds sourced so far
—Latest valuationnot disclosed
Rounds over time log-scaled amounts
Funding history 2 rounds · 3 sources · newest first
Earlier rounds not yet sourced. LifeMine Therapeutics was founded in 2017 and raised before 6 Aug 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.
- Series EAmount$188MPost-money—✓ Confirmed
- Series DAmount$75MPost-money—◔ Reported
- Earlier rounds not yet sourced
Investors 6
- Milky Way Investments1
- ARCH Venture Partners
- Bezos Expeditions
- Gates Frontier
- GV
- RA Capital Management
Highlighted investors led at least one equity round; the number is equity rounds taken part in.
Related companies shared investors
Parabilis MedicinesHealth · $975M in 2025–2026Shared: Milky Way Investments, GV +2OratomicDeep Tech · $775M in 2025–2026Shared: Bezos Expeditions, ARCH Venture PartnersOllin BiosciencesHealth · $430M in 2025–2026Shared: RA Capital Management, ARCH Venture PartnersEncoded TherapeuticsHealth · $275M in 2025–2026Shared: GV, ARCH Venture PartnersSkild AIRobotics · $1.4B in 2025–2026Shared: Bezos ExpeditionsSambaNovaAI Infra · $1.4B in 2025–2026Shared: GV
Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. LifeMine Therapeutics and its logo are trademarks of their owners, used here for identification only.
